Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
This study has been terminated.
( low accrual; loss of funding )
Study NCT00031798 Information provided by Wake Forest University Baptist Medical Center
First Received: March 8, 2002 Last Updated: August 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cognitive/Functional Effects
Depression
Fatigue
Quality of Life
Additional conditions recognized in this trial
Brain Neoplasms
Central Nervous System Neoplasms
Depressive Disorder
Nervous System Neoplasms
More general conditions related to this trial
Behavioral Symptoms
Brain Diseases
Central Nervous System Diseases
Mental Disorders
Mood Disorders
Neoplasms
Neoplasms by Site
Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
methylphenidate hydrochloride
quality-of-life assessment
radiation therapy
Additional drug interventions recognized in this trial
Methylphenidate
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Wake Forest University Baptist Medical Center
National Cancer Institute (NCI)
Back to top of Main Content
